NanoViricides (NNVC) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on NanoViricides (NNVC) is Moderate Underperform.

The composite score behind that read is -0.21, weighing +0.21 of bullish evidence against -0.30 bearish.

NanoViricides last closed at $1.45, +13.28% on the session.

Against the IVW growth benchmark the position is +12.36% over the forecast window.

The read is built from 13 underlying insights — 3 bullish and 10 bearish.

Agreement across those insights is 77%.

16 graded predictions for NNVC so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks NanoViricides in the 12th percentile on return on equity, where 100 is best.

NanoViricides is classified under Health Care / Biotechnology, with a market capitalisation of $32.67M.

StockMap tracks NanoViricides as the 293rd largest of the 344 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 180 Moderate Underperform, 152 Neutral, 11 Strong Underperform and 1 Moderate Outperform.

On that composite NanoViricides ranks 172nd of 344 in the group, against a group median of -0.21.